Videos

Sensimed CEO Discloses Financing, Next Steps

By Mario Admin | November 8, 2016

Sensimed CEO David Bailey recounts his maiden presentation to OIS and shares information on the company’s recent financing, including a commitment from a new strategic…

Read More

InnFocus

By Mario Admin | November 8, 2016

InnFocus, a Santen company, is pioneering novel surgical solutions for treating glaucoma. The company is positioned to be the first FDA approved minimally invasive stand-alone…

Read More

Dempsey Details Shire’s Xiidra Strategy

By Mario Admin | October 31, 2016

Robert Dempsey, head of the ophthalmics franchise for Shire, lays out how Shire rolled out the commercial launch of Xiidra, the company’s new potential blockbuster…

Read More

How Will SightLife Surgical Fill the Cornea Gap?

By Mario Admin | October 26, 2016

Monty Montoya, CEO, introduces SightLife Surgical, the for-profit subsidiary of SightLife that he says will enable the group to complete its mission of eliminating treatable…

Read More

Novaliq

By Mario Admin | October 25, 2016

Novaliq GmbH , a Germany based specialty pharmaceutical company, transforms poorly soluble drugs into effective therapeutics for ophthalmology and derma, using a novel and disruptive…

Read More

Catch Up on OIS@AAO’s Year in Review

By Mario Admin | October 20, 2016

OIS Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH laid out hopeful – and cautionary – signs facing the ophthalmology industry as he kicked off…

Read More

Guerard: Ophthalmology Important to Novartis

By Mario Admin | September 28, 2016

Frederic Guerard, worldwide business franchise head, ophthalmology for Novartis, sits down with OIS TV to explain how the “conscious uncoupling” with Alcon will impact Novartis’…

Read More

A History of OCT-A

By Mario Admin | September 1, 2016

Many see optical coherence tomography (OCT) angiography as a promising new technology, but David Huang, MD, PhD, Peterson professor of ophthalmology at the Casey Eye…

Read More

Welcome to OIS@ASRS

By Mario Admin | August 30, 2016

OIS founder and co-chair Emmett Cunningham Jr., MD, welcomes attendees to the first annual Ophthalmology Innovation Summit held prior to the annual meeting of the…

Read More

Ora’s Shapiro on the Pursuit of Retina’s “Holy Grail”

By Mario Admin | August 30, 2016

Aron Shapiro, vice president at Ora Inc., gives a comprehensive overview of the challenges and opportunities of retina therapies. Shapiro discusses Ora’s early work with…

Read More

History of Intraoperative OCT

By Mario Admin | August 30, 2016

Pars plana vitrectomy is almost a half-century old, and the earliest probes were powered by batteries, said Cynthia A. Toth, MD, the Joseph A.C. Wadsworth…

Read More

Apellis Eyeing 2017 Release of Phase II Results

By Mario Admin | August 30, 2016

Cedric Francois, CEO, Apellis Pharmaceuticals, hopes to deliver positive results to the company’s Phase II clinical trials of APL-2, a peptide targeting the C3 inhibitor…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.